Share This Page
Drug Price Trends for NDC 65862-0309
✉ Email this page to a colleague
Average Pharmacy Cost for 65862-0309
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | 65862-0309-01 | 0.47383 | EACH | 2026-03-18 |
| FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | 65862-0309-01 | 0.51589 | EACH | 2026-02-18 |
| FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | 65862-0309-01 | 0.54606 | EACH | 2026-01-21 |
| FOSINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB | 65862-0309-01 | 0.56234 | EACH | 2025-12-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 65862-0309
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Nexium (Esomeprazole Magnesium) NDC 65862-0309 Market Analysis and Price Projections
This report analyzes the market for esomeprazole magnesium, specifically referencing NDC 65862-0309. The analysis covers current market dynamics, key drivers and challenges, competitive landscape, and price projections for the next five years. The focus is on branded and generic esomeprazole magnesium, with particular attention to factors influencing price fluctuations.
What is the Current Market Landscape for Esomeprazole Magnesium?
The market for esomeprazole magnesium is mature, driven by its efficacy in treating gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. NDC 65862-0309 typically represents a specific formulation or packaging of esomeprazole magnesium. The market is characterized by a significant generic presence following patent expiries of the branded product, Nexium (esomeprazole magnesium) by AstraZeneca.
The global esomeprazole market size was valued at approximately USD 3.5 billion in 2023 [1]. Projections indicate a compound annual growth rate (CAGR) of 3.5% from 2024 to 2030. This growth is primarily attributed to the increasing prevalence of acid-related gastrointestinal disorders worldwide, coupled with the availability of affordable generic options [2].
Key therapeutic areas driving demand include:
- Gastroesophageal Reflux Disease (GERD): This chronic condition, characterized by frequent heartburn and regurgitation, affects a substantial portion of the adult population globally.
- Erosive Esophagitis: A more severe form of GERD where stomach acid damages the lining of the esophagus.
- Peptic Ulcers: Esomeprazole is used in combination therapy to eradicate Helicobacter pylori and prevent recurrence of gastric ulcers.
- Zollinger-Ellison Syndrome: A rare condition involving tumors that produce excess stomach acid.
The pharmaceutical supply chain for esomeprazole magnesium involves active pharmaceutical ingredient (API) manufacturers, formulation companies, distributors, and retail pharmacies. NDC 65862-0309, as a specific product identifier, signifies a particular SKU within this complex distribution network.
What are the Key Drivers and Challenges for Esomeprazole Magnesium Pricing?
Several factors influence the pricing of esomeprazole magnesium, including its NDC 65862-0309.
Market Drivers:
- Increasing Prevalence of Acid-Related Disorders: The growing global population, aging demographics, changing dietary habits, and rising rates of obesity contribute to a higher incidence of GERD and related conditions [2]. This sustained demand underpins market stability.
- Generic Competition: The expiry of patents for branded esomeprazole (Nexium) has led to the entry of numerous generic manufacturers. This intense competition among generic players drives down prices significantly, making the drug more accessible [3].
- Physician Prescribing Patterns: While generic options are available, physician preference for established and well-tolerated medications, along with formulary preferences, can influence brand and generic sales volumes.
- Healthcare Reimbursement Policies: Payer policies, including formulary placement and co-payment structures, directly impact out-of-pocket costs for patients and overall market demand. Government and private insurance plans play a crucial role in pricing accessibility.
- Emerging Markets: Growth in developing economies, with increasing healthcare expenditure and access to medicines, presents an expanding market for both branded and generic esomeprazole.
Market Challenges:
- Price Erosion due to Genericization: The primary challenge is the continuous downward pressure on prices resulting from a highly competitive generic market. This limits profit margins for manufacturers.
- Therapeutic Class Alternatives: While esomeprazole is a proton pump inhibitor (PPI), other PPIs and newer drug classes, such as potassium-competitive acid blockers (P-CABs), represent potential long-term competition, although P-CABs are currently in earlier stages of market penetration for broad indications.
- Regulatory Hurdles: Stringent regulatory requirements for drug approval, manufacturing quality, and pharmacovigilance add to operational costs for manufacturers.
- Supply Chain Disruptions: Geopolitical events, raw material shortages, or manufacturing issues can impact the availability and cost of API and finished drug products.
Who are the Major Players in the Esomeprazole Magnesium Market?
The market for esomeprazole magnesium, including products identified by NDC 65862-0309, is characterized by both branded and generic manufacturers.
Branded Manufacturer:
- AstraZeneca: The originator of Nexium. While facing significant generic competition, AstraZeneca may still market branded esomeprazole magnesium in specific regions or formulations, or through authorized generics.
Key Generic Manufacturers and Marketers (examples, not exhaustive):
- Teva Pharmaceuticals: A major global generic drug manufacturer with a broad portfolio, including esomeprazole.
- Mylan (now Viatris): Another significant player in the generics market, offering esomeprazole products.
- Sun Pharmaceutical Industries: A leading Indian pharmaceutical company with a substantial international presence in generics.
- Dr. Reddy's Laboratories: A prominent Indian pharmaceutical company manufacturing and marketing generic drugs globally.
- Lupin Limited: An Indian multinational pharmaceutical company with a wide range of generic products.
- Perrigo Company: Known for its over-the-counter (OTC) and prescription generic pharmaceuticals.
- Amneal Pharmaceuticals: A US-based manufacturer of generic and specialty pharmaceuticals.
The presence of multiple generic manufacturers for esomeprazole magnesium means that specific NDCs like 65862-0309 can be produced by various entities. The choice of manufacturer by a distributor or pharmacy often depends on pricing, supply reliability, and existing contractual agreements.
What is the Competitive Landscape for Products with NDC 65862-0309?
The competitive landscape for esomeprazole magnesium, particularly for products identified by NDC 65862-0309, is dominated by generic manufacturers. The market is highly fragmented, with numerous companies competing on price and market access.
Key Competitive Factors:
- Price: This is the most critical factor. Generic manufacturers continuously strive to offer the lowest possible price to gain market share and secure contracts with wholesalers and pharmacy benefit managers (PBMs).
- Manufacturing Scale and Efficiency: Larger manufacturers with optimized production processes can achieve lower per-unit costs.
- Supply Chain Robustness: Reliable and consistent supply is crucial. Companies that can ensure uninterrupted availability of their product are favored.
- Regulatory Compliance: Adherence to Good Manufacturing Practices (GMP) and other regulatory standards is non-negotiable and can be a differentiator.
- Formulation and Dosage Forms: While NDC 65862-0309 may specify a particular strength and dosage form (e.g., delayed-release capsules), variations in excipients or release profiles, if any, can exist between manufacturers, though often not clinically significant.
- Market Access and Distribution: Strong relationships with PBMs, wholesalers, and large pharmacy chains are essential for market penetration.
The presence of multiple suppliers for a given NDC can lead to significant price variability. For instance, if NDC 65862-0309 is an off-patent 20mg delayed-release capsule, a pharmacy or distributor could source it from Teva, Sun Pharma, or Dr. Reddy's, with the purchased price differing based on negotiated terms.
What are the Price Projections for Esomeprazole Magnesium (NDC 65862-0309)?
Price projections for esomeprazole magnesium, encompassing products like NDC 65862-0309, are heavily influenced by the ongoing genericization and competitive pressures.
Current Pricing Trends (Approximate, highly variable):
- Branded Nexium (AstraZeneca): Historically, branded esomeprazole magnesium had a high price point. Post-patent expiry, its market share and price have drastically reduced.
- Generic Esomeprazole Magnesium: Prices for generic esomeprazole magnesium vary based on manufacturer, quantity, and channel. A common dosage form like 20mg delayed-release capsules might range from approximately $0.10 to $0.50 per capsule in wholesale acquisition cost (WAC) terms, with actual negotiated prices for large purchasers being lower. For NDC 65862-0309, specific pricing would depend on its exact formulation and the volume purchased.
Price Projections (2024-2029):
| Year | Projected Average Wholesale Acquisition Cost (WAC) Change for Generic Esomeprazole Magnesium | Key Factors Influencing Projection |
|---|---|---|
| 2024 | -2% to -4% | Continued price erosion from intense generic competition; stable demand. |
| 2025 | -3% to -5% | Market saturation of generic offerings; some smaller players may exit or consolidate. |
| 2026 | -2% to -4% | Stabilization of market share among major generic players; focus on supply chain efficiency. |
| 2027 | -1% to -3% | Gradual slowing of price declines as market reaches equilibrium; potential for slight increases due to inflation or supply chain costs for some suppliers. |
| 2028 | -1% to -2% | Continued stability with minor fluctuations driven by input costs and competitor actions. |
| 2029 | -1% to -2% | Long-term stable pricing environment for established generics. |
Note: Projections are for the average WAC of generic esomeprazole magnesium. Actual transaction prices will vary significantly based on volume discounts, PBM negotiations, and payer contracts. NDC 65862-0309 would fall within these general trends.
Factors driving these projections:
- Sustained Generic Competition: The market is unlikely to see a reduction in the number of generic suppliers for esomeprazole magnesium in the near to medium term. This ensures continued price pressure.
- API Cost Fluctuations: The cost of raw materials for esomeprazole magnesium production can fluctuate, impacting manufacturing costs. However, the sheer volume of production often buffers minor shifts.
- Manufacturing Efficiencies: Ongoing process improvements by manufacturers aim to reduce production costs, which can be passed on as lower prices.
- Potential for Therapeutic Shifts: While unlikely to cause a significant price shock in the short term, the eventual broader adoption of novel acid-suppressing agents could gradually impact demand for older PPIs like esomeprazole.
Key Takeaways
The market for esomeprazole magnesium, including products identified by NDC 65862-0309, is characterized by intense generic competition and a mature therapeutic profile. Pricing is primarily driven by the number of generic manufacturers, manufacturing efficiencies, and payer negotiations. Projections indicate a continued trend of modest price erosion for generic esomeprazole magnesium over the next five years, with stabilization expected as the market matures. The underlying demand for esomeprazole magnesium remains robust due to the prevalence of acid-related gastrointestinal disorders.
Frequently Asked Questions
1. What does NDC 65862-0309 specifically refer to in terms of esomeprazole magnesium?
NDC 65862-0309 is a unique product identifier assigned by the U.S. Food and Drug Administration (FDA) to a specific drug product. It typically denotes the manufacturer, product, and packaging size or strength of esomeprazole magnesium. Without access to the FDA's NDC database, the exact details (e.g., specific manufacturer, 20mg delayed-release capsule, 30-count bottle) are not publicly retrievable solely from the NDC number.
2. How does the price of generic esomeprazole magnesium compare to the original branded Nexium?
Generic esomeprazole magnesium prices are substantially lower than the original branded Nexium. Following patent expiry, generic versions typically enter the market at a fraction of the branded price, with further price reductions occurring as more generic competitors emerge.
3. Are there significant quality differences between esomeprazole magnesium from different generic manufacturers (e.g., under NDC 65862-0309 from different suppliers)?
All generic drugs marketed in the U.S. must meet the same bioequivalence and quality standards set by the FDA as the branded drug. Therefore, esomeprazole magnesium products from different manufacturers, including those with the same NDC if manufactured by multiple entities, are expected to be therapeutically equivalent.
4. What is the expected impact of newer acid-suppressing drug classes on esomeprazole magnesium pricing?
Newer drug classes, such as potassium-competitive acid blockers (P-CABs), may gradually shift market share away from traditional proton pump inhibitors (PPIs) like esomeprazole, particularly for certain patient populations or indications where they offer advantages. This potential shift could exert some downward pressure on esomeprazole pricing over the long term as demand diversifies.
5. How can a business professional assess the current market price for a specific NDC like 65862-0309?
Assessing the current market price for a specific NDC requires access to pharmaceutical pricing databases, wholesale drug pricing services (e.g., Red Book, First Databank), or direct engagement with pharmaceutical distributors and wholesalers. These sources provide insights into Average Wholesale Price (AWP), Wholesale Acquisition Cost (WAC), and negotiated contract pricing, which are crucial for R&D or investment decisions.
6. What is the typical dosage and administration for esomeprazole magnesium?
Esomeprazole magnesium is typically administered orally as delayed-release capsules or tablets. Common dosages range from 20 mg to 40 mg once daily, depending on the condition being treated. For example, 20 mg is often used for GERD maintenance and H. pylori eradication, while 40 mg is used for healing erosive esophagitis and treating Zollinger-Ellison syndrome. Patients should follow their healthcare provider's specific instructions regarding dosage and administration.
Cited Sources
[1] Grand View Research. (2024). Esomeprazole Market Size, Share & Trends Analysis Report By Drug Type, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030. Retrieved from https://www.grandviewresearch.com/industry-analysis/esomeprazole-market
[2] Global Market Insights. (2024). Proton Pump Inhibitors Market Size By Drug Type, By Application, By Distribution Channel, By Region, Outlook, Competitive Landscape, Growth Factors, Industry Analysis, Market Share, Trends, Statistics: Global Outlook, 2024 – 2030. Retrieved from https://www.gminsights.com/industry-analysis/proton-pump-inhibitors-market
[3] U.S. Food & Drug Administration. (n.d.). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). Retrieved from https://www.fda.gov/drugs/therapeutic-equivalence-evaluations-orange-book
More… ↓
